Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Tegoprazan

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    Temad- We think of world-class quality.

    Virtual Booth

    Contact Supplier

    Menu

    Tegoprazan

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    $ API Ref.Price (USD/KG) : 11,374Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Reddy's Launches Tegoprazan in India
    Dr. Reddy's Launches Tegoprazan in India

    17 Sep 2025

    // PRESS RELEASE

    https://www.drreddys.com/cms/sites/default/files/2025-09/DRL%20release-%20Tegoprazan-%20final%20version-%2016th%20Sept%202025.pdf

    PRESS RELEASE
    17 Sep 2025
    Share Share
    Metavia Reports Q2 2025 Financial Results, Updates on Corporate
    Metavia Reports Q2 2025 Financial Results, Updates on Corporate

    08 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/metavia-reports-second-quarter-2025-financial-results-and-provides-corporate-update-302523790.html

    PR NEWSWIRE
    08 Aug 2025
    Share Share
    Sebela Pharma Reports Positive Phase 3 Tegoprazan Result in GERD
    Sebela Pharma Reports Positive Phase 3 Tegoprazan Result in GERD

    23 Apr 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-announces-positive-topline-results-from-phase-3-triumph-program-of-tegoprazan-in-gerd-302435337.html

    PR NEWSWIRE
    23 Apr 2025
    Share Share
    Ami Lifesciences Submits US DMF for Tegoprazan
    Ami Lifesciences Submits US DMF for Tegoprazan

    08 Oct 2024

    // PRESS RELEASE

    https://amilifesciences.com/media.php

    PRESS RELEASE
    08 Oct 2024
    Share Share
    Malaysia Approves RaQualia's Tegoprazan For GERD Treatment
    Malaysia Approves RaQualia's Tegoprazan For GERD Treatment

    27 Sep 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/25/24961/malaysia-gives-nod-to-raqualias-tegoprazan-for-gastroesophageal-reflux-disease-treatment.html

    BIOSPECTRUM ASIA
    27 Sep 2024
    Share Share
    Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan
    Sebela Acquires Licensing Rights to Develop and Commercialize Tegoprazan

    20 Oct 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/sebela-pharmaceuticals-acquires-exclusive-licensing-rights-to-develop-and-commercialize-tegoprazan-in-the-us-and-canada-301654039.html

    PRNEWSWIRE
    20 Oct 2022
    Share Share